![]() Amneal Pharmaceuticals Amneal Pharmaceuticals is a company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. | ![]() Sagent Pharmaceuticals Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products. | ![]() Sun Pharma Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company. | Spirovant Sciences Spirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases. | |
Founding Date | Founding Date 2002 | Founding Date 2006 | Founding Date 1983 | Founding Date 2016 |
Type | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | ||||
Locations | Locations Bridgewater Township, US HQ Gröbenzell, DE Ahmedabad, IN Ahmedabad, IN Ahmedabad, IN Dahej, IN Mahabubnagar, IN see more | Locations Schaumburg, US HQ | Locations Mumbai, IN HQ Macquarie Park, AU Dhaka, BD Goiânia, BR Goiânia, BR São Paulo, BR Brampton, CA see more | Locations Philadelphia, US HQ |
Employees | Employees 8,1005% increase | Employees 2261% increase | Employees 43,000 | Employees 234% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) $3b (FY, 2025) | Revenue (est.) $318.3m (FY, 2015) | Revenue (est.) ₹582.2b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.9b (FY, 2025) | Cost of goods $230.6m (FY, 2015) | Cost of goods ₹115.4b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit $1.1b (FY, 2025) | Gross profit $87.7m (FY, 2015) | Gross profit ₹488.9b (FY, 2026) | Gross profit N/A |
Net income | Net income $127.9m (FY, 2025) | Net income ($21.9m) (FY, 2015) | Net income ₹115.6b (FY, 2026) | Net income N/A |

Sagent Pharmaceuticals is focused on developing, manufacturing, sourcing and marketing pharmaceutical products.
View company
Sun Pharma (also known as Sun Pharmaceutical Industries) is a specialty generic pharmaceutical company.
View companySpirovant Sciences is a company focused on the development of gene therapies for treating and curing cystic fibrosis and other lung diseases.
View company